Journal of Cell Science & Therapy
Open Access
ISSN: 2157-7013
+44 1300 500008
ISSN: 2157-7013
+44 1300 500008
Michael P Zahalsky
Posters & Accepted Abstracts: J Cell Sci Ther
Regenerative medicine has often been associated with the process of replacing or reproducing tissues, human cells or organs back to their origin function. Recently, these treatments have involved the use of stem cell technology to treat and manage chronic diseases such as diabetes, heart failure and degenerative nerve, bone and joint conditions. Amniotic fluid is particularly appealing because it contains various proteins, cytokines and a multitude of growth factors that are believed to facilitate angiogenesis while simultaneously preventing inflammation and swelling. ProFlo is amniotic fluid that is minimally manipulated from an FDA cleared tissue bank. We believe that since it is from the genitourinary system, it can be used for homologous use on the genitourinary system. Patients diagnosed with Erectile Dysfunction were injected with ProFlo amniotic fluid and their responses were evaluated using a Penile Doppler to measure pre and post peak systolic velocities. The International Index of Erectile Function Questionnaire (IIEF- 5) was also used to evaluate any changes in erectile function. Overall, results were very encouraging and we observed statistically significant changes in PSV values and IIEF responses. Several patients were satisfied with their treatments, reporting an improvement of erections with minimal to no discomfort. Based on our preliminary findings, ProFlo appears to be a possible alternative for men with erectile dysfunction. The use of amniotic fluid to treat erectile dysfunction is still being evaluated, preliminary results are encouraging but more research needs to be conducted to evaluate its effectiveness and overall safety.
Email: kelly@urostembiologics.com